MUCOLYTICS IN COPD: THE PLOT THICKENS?

1 Gleadhill IC. Should we be using mucolytic agents in the treatment of COPD? J R Coll Physicians Edinb 2006; 36:321–22.

2 Poole PJ Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 3:CD001287. doi: 10.1002/14651858/CD001287.pub2.

3 Demedts M J Behr Buhl R High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005; 353:2229–42.

4 Behr J K Maier Degenkolb B Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis: adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997; 156:1897–1901.

5 Cantin AM SL North Fells GA Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987; 79:1665–73.

6 Decramer M M Rutten-Van Molen Dekhuijzen PN Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005; 365(9470):1552–60.

7 Repine JE A Bast Lankhorst I Oxidative stress in COPD. Am J Respir Crit Care Med 1997; 156:341–357.